MET and hepatocellular carcinoma: For instance, in hepatoma HepG2 cells, a synergistic association exists between the HGF/c-Met and TRK signaling pathways, and the simultaneous inhibition of c-Met and TRKB exhibits a synergistic inhibitory effect on hepatoma [24].